407 related articles for article (PubMed ID: 31892446)
1. Effectiveness of enterovirus A71 vaccine in severe hand, foot, and mouth disease cases in Guangxi, China.
Jiang L; Wang J; Zhang C; He W; Mo J; Zeng J; Chen M; Tan Y; Ning C
Vaccine; 2020 Feb; 38(7):1804-1809. PubMed ID: 31892446
[TBL] [Abstract][Full Text] [Related]
2. Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing, China.
Wang X; An Z; Huo D; Jia L; Li J; Yang Y; Liang Z; Wang Q; Wang H
Hum Vaccin Immunother; 2019; 15(5):1183-1190. PubMed ID: 30779680
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of EV-A71 vaccination in prevention of paediatric hand, foot, and mouth disease associated with EV-A71 virus infection requiring hospitalisation in Henan, China, 2017-18: a test-negative case-control study.
Li Y; Zhou Y; Cheng Y; Wu P; Zhou C; Cui P; Song C; Liang L; Wang F; Qiu Q; Guo C; Zeng M; Long L; Cowling BJ; Yu H
Lancet Child Adolesc Health; 2019 Oct; 3(10):697-704. PubMed ID: 31375313
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Enterovirus 71 inactivated vaccines against hand, foot, and mouth disease: A test-negative case-control study.
Zhang Y; Cui J; Liu F; Song Y; Wang Q; Liu Y; Zhang Y; Li Z; Chang Z
Hum Vaccin Immunother; 2024 Dec; 20(1):2330163. PubMed ID: 38544389
[TBL] [Abstract][Full Text] [Related]
5. [Analysis on epidemiological characteristics of enterovirus 71 cases of hand-foot-mouth disease based on the active monitoring in Guangdong Province in 2011-2015].
Xie DS; He JF; Yang F; Li H; Kang M; Zhang M; Ye X; Tan XH; Ni XH; Hu L; Sun LM
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jul; 52(7):738-742. PubMed ID: 29996302
[No Abstract] [Full Text] [Related]
6. The changes in the epidemiology of hand, foot, and mouth disease after the introduction of the EV-A71 vaccine.
Wang J; Jiang L; Zhang C; He W; Tan Y; Ning C
Vaccine; 2021 Jun; 39(25):3319-3323. PubMed ID: 33994239
[TBL] [Abstract][Full Text] [Related]
7. Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination.
Takahashi S; Liao Q; Van Boeckel TP; Xing W; Sun J; Hsiao VY; Metcalf CJ; Chang Z; Liu F; Zhang J; Wu JT; Cowling BJ; Leung GM; Farrar JJ; van Doorn HR; Grenfell BT; Yu H
PLoS Med; 2016 Feb; 13(2):e1001958. PubMed ID: 26882540
[TBL] [Abstract][Full Text] [Related]
8. Molecular epidemiology and clinical features of hand, foot and mouth disease requiring hospitalization after the use of enterovirus A71 inactivated vaccine in chengdu, China, 2017-2022: a descriptive study.
Duan X; Zhang C; Wang X; Ren X; Peng H; Tang X; Zhang L; Chen Z; Ye Y; Zheng M; Zhong W; Chen X; Zeng Y; Yuan P; Long L
Emerg Microbes Infect; 2022 Dec; 11(1):2510-2519. PubMed ID: 36103331
[TBL] [Abstract][Full Text] [Related]
9. Factors related to the mortality risk of severe hand, foot, and mouth diseases (HFMD): a 5-year hospital-based survey in Guangxi, Southern China.
Peng Y; He W; Zheng Z; Pan P; Ju Y; Lu Z; Liao Y; Wang H; Zhang C; Wang J; Jiang L; Liang H; Chen M; Ye L
BMC Infect Dis; 2023 Mar; 23(1):144. PubMed ID: 36890462
[TBL] [Abstract][Full Text] [Related]
10. The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China.
Jiang H; Zhang Z; Rao Q; Wang X; Wang M; Du T; Tang J; Long S; Zhang J; Luo J; Pan Y; Chen J; Ma J; Liu X; Fan M; Zhang T; Sun Q
Emerg Microbes Infect; 2021 Dec; 10(1):619-628. PubMed ID: 33682641
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of enterovirus A71 vaccine against pediatric HFMD and disease profile of post-vaccination infection.
Duan X; Zhang L; Ding L; Zhang C; Chen Z; Cheng Y; Wang X; Peng H; Tang X; Ren X; Liao J; Yang S; Zhu Y; Luo W; Zeng Y; Yuan P; Long L
Vaccine; 2024 Apr; 42(9):2317-2325. PubMed ID: 38433065
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine.
Yang B; Liu F; Liao Q; Wu P; Chang Z; Huang J; Long L; Luo L; Li Y; Leung GM; Cowling BJ; Yu H
Euro Surveill; 2017 Dec; 22(50):. PubMed ID: 29258646
[TBL] [Abstract][Full Text] [Related]
13. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases.
Mao Q; Wang Y; Bian L; Xu M; Liang Z
Emerg Microbes Infect; 2016 Jul; 5(7):e75. PubMed ID: 27436364
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and managements of severe hand, foot and mouth disease caused by enterovirus A71 and coxsackievirus A16 in Shanghai, China.
Cai K; Wang Y; Guo Z; Yu H; Li H; Zhang L; Xu S; Zhang Q
BMC Infect Dis; 2019 Mar; 19(1):285. PubMed ID: 30917800
[TBL] [Abstract][Full Text] [Related]
15. Is a multivalent hand, foot, and mouth disease vaccine feasible?
Klein M; Chong P
Hum Vaccin Immunother; 2015; 11(11):2688-704. PubMed ID: 26009802
[TBL] [Abstract][Full Text] [Related]
16. [Epidemiological characteristics of fatal cases of hand, foot, and mouth disease in children under 5 years old in China, 2008-2018].
Cui JZ; Nie TR; Ren MR; Liu FF; Li Y; Wang LP; Tan JB; Chang ZR; Li ZJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Jul; 41(7):1041-1046. PubMed ID: 32741167
[No Abstract] [Full Text] [Related]
17. Epidemiological surveillance of hand, foot and mouth disease in Shanghai in 2014-2016, prior to the introduction of the enterovirus 71 vaccine.
Li J; Pan H; Wang X; Zhu Q; Ge Y; Cai J; Li Y; Xia A; Hu J; Zeng M
Emerg Microbes Infect; 2018 Mar; 7(1):37. PubMed ID: 29559626
[TBL] [Abstract][Full Text] [Related]
18. Changing epidemiology of hand, foot, and mouth disease in China, 2013-2019: a population-based study.
Hong J; Liu F; Qi H; Tu W; Ward MP; Ren M; Zhao Z; Su Q; Huang J; Chen X; Le J; Ren X; Hu Y; Cowling B; Li Z; Chang Z; Zhang Z
Lancet Reg Health West Pac; 2022 Mar; 20():100370. PubMed ID: 35036978
[TBL] [Abstract][Full Text] [Related]
19. Spatial-temporal-demographic and virological changes of hand, foot and mouth disease incidence after vaccination in a vulnerable region of China.
Huang L; Wang T; Liu X; Fu Y; Zhang S; Chu Q; Nie T; Tu H; Cheng J; Fan Y
BMC Public Health; 2022 Aug; 22(1):1468. PubMed ID: 35915424
[TBL] [Abstract][Full Text] [Related]
20. Routine Pediatric Enterovirus 71 Vaccination in China: a Cost-Effectiveness Analysis.
Wu JT; Jit M; Zheng Y; Leung K; Xing W; Yang J; Liao Q; Cowling BJ; Yang B; Lau EH; Takahashi S; Farrar JJ; Grenfell BT; Leung GM; Yu H
PLoS Med; 2016 Mar; 13(3):e1001975. PubMed ID: 26978565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
